Stay updated on Nivolumab Safety in Chinese Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Safety in Chinese Solid Tumors Clinical Trial page.
Latest updates to the Nivolumab Safety in Chinese Solid Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe website has added FDA Safety Alerts and Recalls with the new revision v2.11.2, replacing the previous revision v2.11.0.SummaryDifference0.2%
- Check22 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in study record information.SummaryDifference0.8%
- Check30 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference0.7%
- Check44 days agoChange DetectedThe website has been updated to version v2.10.3, with the notable removal of FDA Safety Alerts and Recalls from the previous version v2.10.2.SummaryDifference0.2%
- Check65 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check87 days agoChange DetectedThe study has been updated to version v2.10.0, indicating a new revision from the previous version v2.9.7.SummaryDifference0.3%
Stay in the know with updates to Nivolumab Safety in Chinese Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Safety in Chinese Solid Tumors Clinical Trial page.